Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A transcriptomic microglia taxonomy across mouse and human pathologies.

Nature immunology·2026

Same author

A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer's disease.

Acta neuropathologica·2026

Same author

Correction: Preserved fascicular architecture predicts neuroma pain: a morphometric study.

Acta neuropathologica communications·2026

Same author

Alterations in cerebrospinal fluid levels of myelin- and oligodendrocyte-related proteins in sporadic Creutzfeldt-Jakob disease.

Acta neuropathologica communications·2026

Same author

Unlocking microglia pyroptosis in a model of type I interferon-driven neuroinflammation: lessons from Rnaset2<sup>-/-</sup> mice.

Cell death & disease·2025

Same author

Complement C4d Informs the Differential Diagnosis of Inflammatory Demyelinating CNS Diseases.

Neurology(R) neuroimmunology & neuroinflammation·2025

Same journal

The Noradrenergic Brain in Parkinson's Disease.

Current neurology and neuroscience reports·2026

Same journal

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Current neurology and neuroscience reports·2026

Same journal

Functional and Structural Brain Imaging Correlates of Treatment Response in Functional Movement Disorder.

Current neurology and neuroscience reports·2026

Same journal

Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review.

Current neurology and neuroscience reports·2026

Same journal

When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?

Current neurology and neuroscience reports·2026

Same journal

Assessment and Management of Post-traumatic Headache.

Current neurology and neuroscience reports·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Gray matter pathology and multiple sclerosis.

Christiane Wegner¹, Christine Stadelmann

¹Institute of Neuropathology, University Medical Centre, Göttingen 37099, Germany.

Current Neurology and Neuroscience Reports

|August 12, 2009

Summary

This summary is machine-generated.

Gray matter demyelination is common in multiple sclerosis (MS). This review highlights recent pathology and imaging findings on cortical MS lesions, improving understanding of their clinical impact.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Related Experiment Videos

Last Updated: Jun 21, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Area of Science:

Neurology
Neuroscience
Pathology

Background:

Gray matter demyelination is prevalent in multiple sclerosis (MS).
Distinct pathological features of gray matter lesions complicate detection using conventional imaging.
The clinical impact of gray matter lesions in MS remains poorly understood due to detection challenges.

Purpose of the Study:

To review recent pathological and imaging studies on gray matter demyelination in multiple sclerosis (MS).
To summarize current knowledge on cortical pathology in human and experimental MS.
To elucidate the impact of gray matter lesions on clinical symptoms in MS.

Main Methods:

Review of recent neuropathologic studies on gray matter lesions in MS.
Analysis of advanced imaging techniques for detecting cortical pathology in MS.
Synthesis of findings from human and experimental models of MS.

Main Results:

Gray matter lesions in MS exhibit unique pathological characteristics.
Conventional imaging methods are insufficient for detecting these cortical lesions.
Recent advancements in imaging show promise for improved detection and understanding.

Conclusions:

Gray matter demyelination is a significant feature of MS pathology.
Improved detection of cortical lesions is crucial for understanding MS pathogenesis and clinical outcomes.
Further research integrating pathology and advanced imaging is needed to define the role of gray matter lesions in MS.